First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South Korea.
Anticancer Res
; 42(3): 1615-1622, 2022 Mar.
Article
in En
| MEDLINE
| ID: mdl-35220259
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biomarkers, Tumor
/
Carcinoma, Non-Small-Cell Lung
/
Protein Kinase Inhibitors
/
Afatinib
/
Lung Neoplasms
/
Mutation
/
Antineoplastic Agents
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
En
Journal:
Anticancer Res
Year:
2022
Document type:
Article
Country of publication:
Greece